in this issue
Regions :: Western Europe :: France
Minakem Acquires API Plant from AstraZeneca
9:59 AM MDT | May 29, 2009
Pharmaceutical intermediates and active pharma ingredients (API) manufacturer Minakem (Beuvry-la-Forêt, France) has completed the acquisition of a multi-purpose API plant at Dunkirk, France from AstraZeneca. Minakem says it has also signed a long-term contract with AstraZeneca to supply budesonide, omeprazole, and esomeprazole. Financial details of the deal were not disclosed. The deal brings Minakem significant manufacturing capabilities and raises its custom synthesis capacity, Minakem says. The increased capacity will also help to reduce API costs, the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee